Options trader full-time, author, owner of www.kevinmobrien.com, a subscription-based trading service. Born in Chicago, IL. I trade many stocks in the tech, financial, and agricultural sectors. Trade daily with a 5 Technical Indicator Strategy I developed, the Daily Options Trading Strategy (DOTS). Also trade many debit spreads for weekly and earnings-based trades such as Strangles, the Reverse Iron Condor, the Neutral Calendar Spread and also hold long-term call and put options on undervalued stocks and ETF's.
If you are interested in subscribing to the website's Trading Forum, please visit us at www.kevinmobrien.com.
Favorite stocks to trade: CF, GOOG, AAPL, NFLX, BIDU, CMG, PCLN, RIMM, CSCO, IDCC, POT, MOS, MON, SNDK, APA, and many more.
I'm a big Chicago Bears and Blackhawks fan.
Most people follow the path of least resistance making poor dietary and health choices. People also spend their discretionary income and credit on retail, shiny computer gadgets, smartphones, and cable TV instead of on retirement savings. One can profit from this behavior by buying stock in companies that support other people's bad decisions.
I focus on investing long-term in high-quality, dividend-paying companies that tap into poor lifestyle choices across the economic spectrum.
I'm long on companies like Coca-Cola (sugar water), Kraft, and Mondelez (pre-packaged junk food), Altria and Philip Morris, Int (smokers), Abbott and AbbVie (drugs and equipment to treat poor lifestyle choices), Intel (computer chips to support shiny gadgets & now mobile phones too), Disney and Comcast for entertainment, internet and cable, and of course who can forget booze (Diageo) and lattes (Starbucks).
And since most people don't have a lot of money saved, one can profit from stores that sell cheap clothing (TJX Companies), banks to lend them money (Wells Fargo), and energy to move them about and heat their homes (Williams Companies and Chevron).
My complete portfolio currently consists of the following stocks:
AbbVie Inc (ABBV)
Abbott Laboratories (ABT)
Chevron Corporation (CVX)
Diageo Plc (DEO)
Emerson Electric Co (EMR)
Gramercy Properties Trust (GPT)
The Home Depot (HD)
Intel Corporation (INTC)
The Coca-Cola Company (KO)
The Kraft Heinz Company (KHC)
McCormick & Company (MKC)
Mondelez International Inc (MDLZ)
Altria Group Inc (MO)
Norfolk Southern Company (NSC)
Proctor & Gamble (PG)
The TJX Companies, Inc. (TJX)
Union Pacific Corporation (UNP)
The Walt Disney Company (DIS)
Wells Fargo & Co (WFC)
Williams Companies (WMB)
I am an undergraduate finance student and value investor influenced by the likes of Buffett, Graham, Marks, Klarman, Greenblatt, etc. I am currently interning for a value oriented fund based in Texas, and I’m also searching for an internship for summer 2017. I can be contacted by phone at 1-508-505-8910 or e-mail at firstname.lastname@example.org.
For a little more background…
I started reading Graham and Buffett when I was around 14 or 15 years old and quickly began to develop a passion for value investing. People often say that something just “clicks” and that’s certainly what happened for me. I began investing my own money shortly after and then began to write for Seeking Alpha in my junior year of high school. I have come quite a long way as an investor since then, as you can see by looking at the comparative simplicity of some of my earliest articles.
Over time, my investment philosophy has developed into a strictly value oriented approach, but this does not mean we need to make value and growth a dichotomy. Some companies might be a buy at 25x earnings while others might be a sell at 10x earnings. Through a thorough analysis of competitive and other qualitative factors, along with a valuation through DCF and/or comparable company multiples, I will ultimately arrive at my decision whether to buy, sell, or do nothing. Most of the time I don’t do anything. I aim to only purchase stocks when, simply put (and it’s much more complicated in practice), not everything has to go right in order for the investment to work out. Although I think the strong form EMH is quite ridiculous and has been disproven by various track records, I’m willing to admit that it’s quite difficult to find a security that has an adequate margin of safety worked in. It requires that I constantly try to turn over more rocks.
Although I originally started writing for Seeking Alpha as a way to increase my knowledge and earn a little bit of spending money, its primary use has now developed into serving as my investment journal. I will give each idea I write up a thorough qualitative and quantitative overview, and make my decision based on the findings. I will continually revisit past works to see how the idea has been developing and where I may have gone wrong so that I can avoid similar mistakes in the future. I welcome any and all feedback on my articles, and please feel free to reach out if you wish to contact me for whatever reason (information above).
Analyst and Fund Manager with almost 20 years investment experience. Coverage includes a variety of industries, with a focus on technology.
Particularly focused on value stocks, poorly understood or under-followed situations, and contrarian perspectives.
Primarily invest in special situations with value that is poorly understood or not fully appreciated, or where we believe there is a highly asymetric risk/reward profile. Also look for long/short ideas in mid/larger cap names where we believe we have a variant view, and the market is dramatically mispricing value.
Follow me on Twitter @valinsights
I am a former hedge fund portfolio manager that trades for my own personal account. I espouse Graham and Dodd/Buffett style investing, always on the lookout for value equities or bonds. A graduate of Northwestern's Kellogg School of Management, I lived in NYC for a decade before relocating with my family to the Charlotte, NC area in 2007.
Peter Geschek is a freelance writer, investor and the publisher of www.medfrontiers.com website. This is a site for medical innovation news and clinical trials news. Short, concise, important information about the latest is biotech and pharmaceuticals.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
I am currently a Junior at the George Washington University and have been investing since the sixth grade with my own money. I am very interested in the pharmaceutical sectors, but will buy just about any stock if I feel that the company is undervalued. I hope to provide some helpful insight, and to in turn learn a lot from the rest of the investment community.